Kamada Ltd.
HealthcareNASDAQ:KMDA · NASDAQ Global Select
+$0.00 today
Vol 0.03M · Avg 0.06M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $32.9M |
| Short-term Investments | $40.2M |
| Receivables | $40.7M |
| Inventory | $85.4M |
| Total Current Assets | $199.2M |
| PP&E (Net) | $50.4M |
| Goodwill | $30.3M |
| Intangible Assets | $95.7M |
| Other Non-current | $7.4M |
| Total Non-current Assets | $183.8M |
| Total Assets | $383.0M |
Analysis
Selected assets total $383.0M for Latest. The largest visible component is Intangible Assets at $95.7M, about 25.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75.5M -3.8% | $78.4M +41.0% | $55.6M +62.4% | $34.3M +84.3% | $18.6M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $29.0M +25.2% | $23.2M +9.0% | $21.3M -24.9% | $28.4M -20.3% | $35.6M | $533.8M | $399.4M | -$1.7B |
| Inventory | $85.0M +7.8% | $78.8M -10.9% | $88.5M +22.0% | $72.5M +1.0% | $71.8M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $0 -100.0% | $49.0K -67.1% | $149.0K | $0 -100.0% | $73.0K | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $193.1M +4.8% | $184.3M +8.5% | $170.0M +22.3% | $139.0M +6.9% | $130.0M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $50.3M +9.6% | $45.9M +27.4% | $36.0M +25.3% | $28.7M -2.3% | $29.4M | $1.2B | $1.5B | $687.8M |
| Goodwill | $30.3M +0.0% | $30.3M +0.0% | $30.3M +0.0% | $30.3M +0.0% | $30.3M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $96.1M -5.6% | $101.9M -7.1% | $109.6M -6.0% | $116.7M -5.3% | $123.3M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $7.5M | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 -100.0% | $488.0K | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $1.4M -84.9% | $9.4M +4.2% | $9.0M +17.9% | $7.6M +35.7% | $5.6M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $185.7M -1.2% | $187.9M +1.6% | $184.9M +0.9% | $183.4M -2.8% | $188.6M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $378.8M +1.8% | $372.3M +4.9% | $354.9M +10.1% | $322.4M +1.2% | $318.7M | $13.3B | $11.9B | $10.6B |
| Account Payables | $23.2M -16.2% | $27.7M +11.8% | $24.8M -24.6% | $32.9M +31.1% | $25.1M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $2.1M | $0 | $0 -100.0% | $4.4M +68.9% | $2.6M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 -100.0% | $171.0K -47.4% | $325.0K +37.7% | $236.0K -4.5% | $247.0K | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $11.8M -39.3% | $19.4M -13.9% | $22.5M -38.2% | $36.5M +49.9% | $24.3M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $47.4M -4.0% | $49.4M -0.4% | $49.6M -34.5% | $75.7M +40.0% | $54.1M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $0 | $0 | $0 -100.0% | $13.0M -25.5% | $17.4M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $1.7M | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 -100.0% | $15.0K | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $51.2M -5.2% | $54.0M +0.2% | $53.9M -3.0% | $55.5M -17.4% | $67.2M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $62.3M -1.8% | $63.4M +3.4% | $61.3M -13.2% | $70.7M -19.5% | $87.8M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $109.7M -2.8% | $112.8M +1.7% | $110.9M -24.2% | $146.4M +3.2% | $141.8M | $14.7B | $3.7B | $9.6B |
| Common Stock | $15.1M +0.4% | $15.0M +0.0% | $15.0M +28.0% | $11.7M +0.1% | $11.7M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$17.1M +33.6% | -$25.7M +36.0% | -$40.2M +17.1% | -$48.5M -5.0% | -$46.2M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $2.8M +190.5% | -$3.1M +0.0% | -$3.1M +4.8% | -$3.2M +9.9% | -$3.6M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 -100.0% | $6.3M -1.7% | $6.4M +16.7% | $5.5M +18.6% | $4.6M | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $269.1M +3.7% | $259.5M +6.3% | $244.0M +38.6% | $176.0M -0.5% | $176.8M | $9.1B | $7.7B | $3.3B |
| Total Debt | $11.6M +4.5% | $11.1M +25.4% | $8.8M -57.2% | $20.6M -15.4% | $24.4M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$63.9M +5.1% | -$67.4M -43.9% | -$46.8M -242.8% | -$13.7M -336.9% | $5.8M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Tactile Systems Technology, Inc.
NASDAQ:TCMD
$593.46M
Solid Biosciences Inc.
NASDAQ:SLDB
$556.28M
XOMA Royalty Corp.
NASDAQ:XOMA
$524.09M
Evolus, Inc.
NASDAQ:EOLS
$443.20M
PureTech Health plc
NASDAQ:PRTC
$424.07M
Auna S.A.
NYSE:AUNA
$364.93M
Semler Scientific, Inc.
SMLR
$310.75M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$300.28M
Quantum-Si incorporated
NASDAQ:QSI
$187.28M
Galectin Therapeutics Inc.
NASDAQ:GALT
$175.84M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does KMDA have?
Kamada Ltd. (KMDA) reported $75.48M in cash and equivalents in fiscal 2025.
How much debt does KMDA carry?
Kamada Ltd. (KMDA) reported $11.56M of total debt, with net debt of -$63,921,267.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.